US Stock MarketDetailed Quotes

Exelixis (EXEL)

Watchlist
  • 54.070
  • +1.870+3.58%
Close Aug 7 16:00 ET
  • 54.070
  • 0.0000.00%
Post 20:02 ET
13.40BMarket Cap17.00P/E (TTM)

About Exelixis Company

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Company Profile

SymbolEXEL
Company NameExelixis
Listing DateApr 11, 2000
Issue Price13.00
ISINUS30161Q1040
Founded1994
CEODr. Michael M. Morrissey, PhD
MarketNASDAQ
Employees4600
Fiscal Year Ends12-31
Address1851 Harbor Bay Parkway
CityAlameda
ProvinceCalifornia
CountryUnited States of America
Zip Code94502
Phone1-650-837-7000
Websitehttp://www.exelixis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael M. Morrissey, PhD
  • Director, President and Chief Executive Officer
  • 33.24M
  • Christopher J. Senner
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 10.65M
  • Patrick J. Haley
  • Executive Vice President, Commercial
  • 9.02M
  • Dr. Dana T. Aftab, PhD
  • Executive Vice President, Research and Development
  • 10.54M
  • Dr. Brenda Hefti, J.D.,PhD
  • Senior Vice President and General Counsel
  • 4.20M
  • Dr. Stelios Papadopoulos,PhD
  • Chairman of the Board
  • 555.74K
  • Julie Anne Smith
  • Independent Director
  • 520.49K
  • Tomas J. Heyman
  • Independent Director
  • 517.49K
  • Robert Oliver, M.B.A.
  • Independent Director
  • 501.99K
  • Jack L. Wyszomierski, M.S.
  • Independent Director
  • 519.99K
  • David E. Johnson
  • Independent Director
  • 507.21K
  • Dr. Sue Gail Eckhardt, M.D.
  • Independent Director
  • 504.49K
  • Dr. Mary C. Beckerle, PhD
  • Independent Director
  • 513.49K
  • Dr. Maria C. Freire, PhD
  • Independent Director
  • 517.49K
  • Dr. George H. Poste, D.V.M.,F.R.S.,PhD
  • Independent Director
  • 514.99K
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.34%
Sample Name
Sample Code
 +8.54%
Sample Name
Sample Code
 +8.47%
4
ProShares Ultra Energy
DIG
+7.88%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+6.72%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +27.64%
Sample Name
Sample Code
 +13.73%
Sample Name
Sample Code
 +11.86%
4
Kingsoft Cloud
KC
+10.58%
5
ASE Technology
ASX
+6.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -